| Jack Tyrone Adcock, DO | |
|
3401 Mcintosh Cir Ste 200, Joplin, MO 64804-3604 | |
| (417) 347-3703 | |
| (417) 347-3727 |
| Full Name | Jack Tyrone Adcock |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 32 Years |
| Location | 3401 Mcintosh Cir Ste 200, Joplin, Missouri |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669487054 | NPI | - | NPPES |
| 245800602 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VG0400X | Obstetrics & Gynecology - Gynecology | 2001025553 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Freeman Health System - Freeman West | Joplin, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Freeman-oak Hill Health System | 8325942253 | 316 |
News Archive
Spectrum Health will be the first health system in West Michigan and among the first in the nation to offer treatment with a newly FDA-approved device that uses electric stimulation of the brain for adult epilepsy patients whose seizures have not responded to medication.
Clinical researchers at VCU Massey Cancer Center have successfully completed a Phase I clinical trial evaluating a combination of the drugs Bortezomib and Alvocidib in patients with relapsed or refractory blood cancers, paving the way for a Phase II clinical trial to test the safety and effectiveness of the new therapy.
Delcath Systems, Inc. announced that updated results from the metastatic neuroendocrine tumor (mNET) cohort of the Company's recently completed Phase 2 clinical trial were presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress held this week in Munich, Germany.
A national study measuring parental attitudes toward vaccinations found 6.1% were hesitant about routine childhood immunizations while nearly 26% were hesitant about the influenza vaccine.
› Verified 7 days ago
| Entity Name | Freeman-oak Hill Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679517023 PECOS PAC ID: 8325942253 Enrollment ID: O20040218000570 |
News Archive
Spectrum Health will be the first health system in West Michigan and among the first in the nation to offer treatment with a newly FDA-approved device that uses electric stimulation of the brain for adult epilepsy patients whose seizures have not responded to medication.
Clinical researchers at VCU Massey Cancer Center have successfully completed a Phase I clinical trial evaluating a combination of the drugs Bortezomib and Alvocidib in patients with relapsed or refractory blood cancers, paving the way for a Phase II clinical trial to test the safety and effectiveness of the new therapy.
Delcath Systems, Inc. announced that updated results from the metastatic neuroendocrine tumor (mNET) cohort of the Company's recently completed Phase 2 clinical trial were presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress held this week in Munich, Germany.
A national study measuring parental attitudes toward vaccinations found 6.1% were hesitant about routine childhood immunizations while nearly 26% were hesitant about the influenza vaccine.
› Verified 7 days ago
| Entity Name | Care For Women Joplin Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891199782 PECOS PAC ID: 1850614413 Enrollment ID: O20150106002444 |
News Archive
Spectrum Health will be the first health system in West Michigan and among the first in the nation to offer treatment with a newly FDA-approved device that uses electric stimulation of the brain for adult epilepsy patients whose seizures have not responded to medication.
Clinical researchers at VCU Massey Cancer Center have successfully completed a Phase I clinical trial evaluating a combination of the drugs Bortezomib and Alvocidib in patients with relapsed or refractory blood cancers, paving the way for a Phase II clinical trial to test the safety and effectiveness of the new therapy.
Delcath Systems, Inc. announced that updated results from the metastatic neuroendocrine tumor (mNET) cohort of the Company's recently completed Phase 2 clinical trial were presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress held this week in Munich, Germany.
A national study measuring parental attitudes toward vaccinations found 6.1% were hesitant about routine childhood immunizations while nearly 26% were hesitant about the influenza vaccine.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jack Tyrone Adcock, DO Po Box 3810, Joplin, MO 64803-3810 Ph: (417) 347-4662 | Jack Tyrone Adcock, DO 3401 Mcintosh Cir Ste 200, Joplin, MO 64804-3604 Ph: (417) 347-3703 |
News Archive
Spectrum Health will be the first health system in West Michigan and among the first in the nation to offer treatment with a newly FDA-approved device that uses electric stimulation of the brain for adult epilepsy patients whose seizures have not responded to medication.
Clinical researchers at VCU Massey Cancer Center have successfully completed a Phase I clinical trial evaluating a combination of the drugs Bortezomib and Alvocidib in patients with relapsed or refractory blood cancers, paving the way for a Phase II clinical trial to test the safety and effectiveness of the new therapy.
Delcath Systems, Inc. announced that updated results from the metastatic neuroendocrine tumor (mNET) cohort of the Company's recently completed Phase 2 clinical trial were presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress held this week in Munich, Germany.
A national study measuring parental attitudes toward vaccinations found 6.1% were hesitant about routine childhood immunizations while nearly 26% were hesitant about the influenza vaccine.
› Verified 7 days ago
Jeffrey Cox, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1532 W 32nd St, Ste 201, Joplin, MO 64804 Phone: 417-347-8660 Fax: 417-347-8691 | |
Oman E Dement, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1532 W 32nd St, Ste 401, Joplin, MO 64804 Phone: 417-347-7009 Fax: 417-347-3288 | |
Cheryl A Fogarty, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3103 Mcclelland Blvd, Joplin, MO 64804 Phone: 417-624-2621 Fax: 417-624-4652 | |
Miss Jessica B Windschitl, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1532 W 32nd St Ste 301, Joplin, MO 64804 Phone: 417-347-2525 Fax: 417-347-8991 | |
Dr. Terry Keith Grebe, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2736 E 15th St, Joplin, MO 64804 Phone: 417-782-0166 Fax: 417-782-0166 | |
Christopher H. Roberts, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2216 E 32nd St Ste 101, Joplin, MO 64804 Phone: 417-622-0911 Fax: 417-622-0730 |